Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Cellceutix to Commence Clinical Trials for Its Novel Anti-Cancer Drug Kevetrin
Yahoo
Monday, September 24, 2012 - 10:32am
tags:
Cellceutix, Kevetrin, small molecule drugs
Spectrum Pharma Not Ready to Call Lymphoma Study a Win
TheStreet.com
Monday, September 24, 2012 - 10:30am
tags:
Spectrum Pharmaceuticals, lymphoma, belinostat, TopoTarget, peripheral T-cell lymphoma
Galderma and NovaBay Enroll First Patients in Phase 2b Clinical Study of NVC-422 for Impetigo
Yahoo
Monday, September 24, 2012 - 10:23am
tags:
Galderma, NovaBay, NVC-422, impetigo
A New Reason to be Bullish About Sarepta Therapeutics
TheStreet.com
Monday, September 24, 2012 - 10:22am
tags:
Sarepta Therapeutics, eteplirsen, Duchenne Muscular Dystrophy
Novartis: RLX030 reduced deaths in patients with acute heart failure
Yahoo/Fly on the Wall
Monday, September 24, 2012 - 10:21am
tags:
RLX030, heart failure, Novartis, serelaxin
R&D and launch of new generic drugs to up US biz: Wockhardt
CNBC
Sunday, September 23, 2012 - 12:55pm
tags:
Wockhardt
Are Staph Infection Vaccines on the Cusp?
Wall Street Cheat Street
Sunday, September 23, 2012 - 12:53pm
tags:
Pfizer, NovaDigm Therapeutics, GSK, MRSA, staph infection, vaccines
Big Pharma Faces its China Moment
Motley Fool
Sunday, September 23, 2012 - 12:52pm
tags:
A Primer on the Health-Care Sector
Motley Fool
Sunday, September 23, 2012 - 12:50pm
tags:
Questcor: Primed For A Big Bounce
Seeking Alpha
Sunday, September 23, 2012 - 12:50pm
tags:
Questcor Pharmaceuticals
US FDA approves Acton Pharma's Aerospan to treat asthma
Pharmabiz
Saturday, September 22, 2012 - 5:07pm
tags:
Acton Pharmaceutical, Aerospan, asthma
Mitsui's stake buy in Arch Pharma gets CCI nod news
domain-b
Saturday, September 22, 2012 - 5:05pm
tags:
Arch Pharmalabs
Faster FDA Review Process a Contributing Factor to Biotech Industry Rise in 2012
Melodika
Saturday, September 22, 2012 - 3:59pm
tags:
Acura Pharmaceuticals Announces Paragraph IV ANDA Filing for OXECTA(R)
Healthcare Global
Saturday, September 22, 2012 - 3:55pm
tags:
Acura, Oxecta, pain management
3 Pharmaceutical Stocks to Buy Now
InvestorPlace
Saturday, September 22, 2012 - 3:53pm
tags:
Cumberland, Zogenix, Acura Pharmaceuticals
Astex Pharmaceuticals Discontinues Amuvatinib Clinical Development Program
Pipeline Review
Saturday, September 22, 2012 - 3:52pm
tags:
amuvatinib, Astex
Doctors found to lack trust in drug company studies
LA Times, CA
Saturday, September 22, 2012 - 3:51pm
tags:
K-V Pharma Protests Hologic Bid to Reacquire Drug
4-Traders
Saturday, September 22, 2012 - 3:50pm
tags:
KV Pharmaceutical, Hologic, Makena
Valeant Pharmaceuticals International, Inc. Announces Pricing Of Concurrent Private Offerings Of Senior Notes By Valeant Pharmaceuticals International, Inc.
Sacramento Bee, CA
Saturday, September 22, 2012 - 3:49pm
tags:
Valeant Pharmaceuticals
Valuing Drug Stocks
Seeking Alpha
Saturday, September 22, 2012 - 3:38pm
tags:
JNJ, Merck, Pfizer, Abbott Laboratories

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.